Table 3.
Baseline Characteristics | Patients with Neuroendocrine Tumours (n = 101) | |
---|---|---|
Age: years, mean ± SD | 55.7 ± 12.1 | Std. Err.: 1.2 |
Gender, (male/female), n (%) | 51/50 (50.5%/49.5%) | |
Neuroendocrine tumours (NETs) localization, n (%) thyroid lung pheochromocytoma pancreas gastroenteropancreatic other locations |
24 (23.8) 13 (12.9) 6 (5.9) 17 (16.8) 34 (33.7) 7 (6.9) |
− |
Grade, n (%) G1 G2 G3 Unknown |
20 (19.8) 35 (34.7) 9 (8.9) 37 (36.6) |
− |
Ki67%, mean ± SD | 13.4 ± 13.8 | Std. Err.: 1.8 |
Metastasis (Yes/No), n (%) | 65/36 (64.4/35.6) |
SD, standard deviation; Std. Err., standard error.